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http://dx.doi.org/10.1016/j.kjms.201Abstract Gastrointestinal nodular lymphoid hyperplasia is a rare lymphoproliferative state.
In children, it is associated with familial immunodeficiency disease but most cases have no
obvious etiology. In adults, nodular lymphoid hyperplasia is associated with immunocompro-
mised status, including chemotherapy, acquired immunodeficiency viral infection, organ trans-
plantation, and multiple polypoid lesions are noted in endoscopic findings and sometimes may
be confused with family polypoid syndrome. We present a child with histological proof of focal
intestinal nodular lymphoid hyperplasia that had a complete image study including negative
results of 18F-fluoro-2-deoxyglucose positron emission tomography/computerized tomography
analysis.
Copyright ª 2012, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, 68 ZhongHua 3rd Road, Cianjin District,
(Y.-C. Su).
hsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
2.11.008
Figure 1. Computed tomography of the abdomen with
enhancement showing enlarged lymph nodes (size, 0.5e1.5 cm)
in the right lower quadrant of themesenteric space (as shown by
the arrow).
Figure 2. Colonoscopy showingmultiple small nodularmasses
without ulceration or mucosal change at the terminal ileum.
Endoscopic and PET imaging for NLH 397Introduction
Nodular lymphoid hyperplasia (NLH) is a rare lymphoproli-
ferative state that is not pathognomonic of a specific
disease [1]. Its diagnosis is based on pathological findings of
hyperplasic lymphoid follicles, mitotically active germinal
centers with well-defined lymphocytic mantles, and
lymphoid follicles localized at mucosa and/or submucosa.
Its cause remains unknown but there is a hypothesis that it
originates from proliferative plasma cell precursors which
compensate for functionally inadequate intestinal
lymphoid tissue due to a maturational defect in the
development of B lymphocytes [2]. Because NLH is
frequently associated with either several benign or malig-
nant diseases in adults [3], it is important to elucidate
between benign NLH and malignant lymphoma.
Case report
A 15-year-old boy consulted the emergency room of the
Kaohsiung Medical University Hospital due to recurrent
abdominal pain around the umbilical area for 2 weeks. The
pain was characterized as dull and lasted for hours. There
was no specific aggravating factor. The symptoms usually
subsided after defecation or assuming a knee-to-chest
position. The patient had an unremarkable past and
family history. He was fully immunized.
At the emergency room, the patient’s body tempera-
ture was 36.5C, pulse rate 93 beats/minute, respiratory
rate 14/minute, and blood pressure 107/77 mmHg.
Abdominal physical examination showed tenderness
around the periumbilical area without rebound pain or
muscle guarding. Complete blood count showed no leuko-
cytosis (white blood cell count 6.98 * 109/L, 4.40w11.30 *
109/L) or anemia (hemoglobin 14.3 g/L, 14w17.5 g/L, and
hematocrit 0.42, 0.42w0.50). Blood biochemistry was also
unremarkable (asparate aminotransferase 23 U/L, 10w42
U/L; alanine aminotransferase 13 U/L, 10w40 U/L; blood
ureas nitrogen 3.46 mmol/L, 2.85w7.14 mmol/L and
creatinine 53.04 mmol/L, 53.04w114.92 mmol/L). Plain
abdominal X-rays showed moderate gathering of bowel gas
at the central lower abdomen, whereas abdominal
computed tomography (CT) imaging disclosed enlarged
lymph nodes in the right lower quadrant of the mesenteric
space (Fig. 1).
Subsequent esophagogastroduodenal endoscopy exami-
nation was unremarkable. Colonoscopy revealed numerous
small nodular masses through the terminal ileum (Fig. 2).
To further evaluate the extent of these lesions, follow-
through series barium study of the small intestine was
conducted, which showed nodular wall thickening of the
terminal ileum, ileocecal valve, and cecum (Fig. 3).
Serial laboratory studies showed mildly elevated plasma
levels of lactate dehydrogenase (LDH) 199 IU/L (normal
range, 91e180 IU/L) and erythrocyte sedimentation rate
(ESR) 15 mm/hour (normal range, 1e10 mm/hour). There
was no fecal parasite found. Immunoglobulin (Ig) G level
was 1210 mg/dL (normal range, 917.2e1891.2 mg/dL), IgA
115 mg/dL (normal range, 183.9e322.3 mg/dL), and IgM
138 mg/dL (normal range, 102.6e125.5 mg/dL). Plasma
complement C3 and C4 levels were within normal limits at106 mg/dL and 22.4 mg/dL, respectively. Antinuclear
antibody (ANA) was negative.
Pathological findings of the biopsy specimen from the
nodular mass in the terminal ileum via colonoscopy showed
hyperplasia polyps with chronic inflammation over the
terminal ileum.
To evaluate the nature of enlarged mesenteric lymph
nodes found on the abdominal CT scan, 18F-fluoro-2-
deoxyglucose positron emission tomography (PET) was
performed (Fig. 4).
Repeated attacks of abdominal pain were noted and the
patient was admitted to the pediatric ward 2 months later.
A second examination session revealed similar findings as
the previous colonoscopic examination in the terminal
ileum. A laparoscopic intra-abdominal lymph node biopsy
was performed (Figs. 5e7).
Figure 5. Laparoscopic examination showing several
enlarged lymph nodes around the terminal ileum and cecum.
Figure 3. Small intestine series showing nodular wall thick-
ening involving the terminal ileum, ileocecal valve, and cecum.
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NLH is recognized in the pediatric population with more
prevalence than the adult population with concomitantFigure 4. PET showing no obvious FDG avid lesion in the
gastrointestinal tract.common variable immunodeficiency. The most common
sites involved are the small bowel or colon in primary
immunodeficiency syndrome, or the terminal ileum or colon
in children without immunodeficiency [1]. Gastric involve-
ment is rare. NLH is often an incidental finding, especially
by endoscopic and histopathological confirmation without
specific symptoms. Its diagnosis is based on characteristic
pathological findings, with lymphoid infiltrates confined to
the lamina propria and superficial submucosa. In differen-
tial diagnosis, lymphoid hyperplasia of the gastrointestinal
tract can be distinguished from malignant lymphoma by the
polymorphic nature of the infiltrates, absence of significant
cytologic atypia, and presence of reactive follicles within
the lesion [3].
Some patients may suffer from diffuse abdominal pain,
intussusception, or gastrointestinal tract hemorrhage [4].
Rubio-Tapia et al. reported leading symptoms of duodenal
NLH in 18 adults are diarrhea, involuntary weight loss, and
abdominal pain [5]. In children, the clinical course of NLH isFigure 6. Multiple aggregations of lymphoid cells with
germinal center formation.
Figure 7. Lymphoid cell aggregation in the lamina propria.
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contrast, adult patients are often associated with immu-
nodeficiency (e.g., common variable immunodeficiency,
selective IgA deficiency) and giardiasis [6], and are predis-
posed to developing primary lymphoma of the gastrointes-
tinal tract [7].
This case report was completely assessed with PET
imaging and laparoscopic lymphectomy to exclude any
malignant potential of enlarged lymph nodes located both
in the intestinal mucosa and mesentery. 18F-Fluoro-2-
deoxyglucose positron emission tomography (FDG-PET) is
based on increased glycolysis of cancer cells. The agent is
the radioactive glucose analog FDG, which is metabolically
trapped within the cell after phosphorylation [8]. The
degrees of uptake by PET imaging between benign and
malignant lymphoma are variable. Metser et al. reported on
33 patients with mucosa-associated lymphoid tissue
lymphoma, and only 25% of patients had either suspected or
proven malignancy demonstrating increased uptake. The
lesions without FDG avid can be mistaken as benign lesions
[9]. Some lymphomas, including Hodgkin’s lymphoma,
diffuse large B cell lymphoma, and follicular lymphoma are
routinely FDG avid [10]. In general, aggravating lymphoma
usually shows high uptake; however, the indolent may be
less FDG avid in PET imaging.
Lymphoma can be mimicked clinically by a broad range
of disease entities and conditions, from infectious,
inflammatory, and autoimmune conditions and drug reac-
tions to benign lymphoproliferative disorders. In a system-
atic review of PET/CT studies performed in oncological
patients during a 6-month period, there was benign non-
physiological uptake of 18F-FDG in more than 25% of
patients. In half of these, 18F-FDG uptake was moderate or
marked in intensity, similar to that of malignant sites. A
total of 73% of benign lesions were inflammatory in nature,with post-traumatic bone and soft-tissue abnormalities
(including iatrogenic injury), whereas benign tumors
accounted for the rest [10]. There is also a report on
nodular lymphoid lesions mimicking low-grade malignant
lymphoma in the liver [11].
Fusion imaging with PET/CT has been shown to improve
not only the sensitivity of PET interpretation but also its
specificity [12]. The gold standard is tissue biopsy to
confirm the diagnosis. In the current concept, PET/CT is
superior in following up the lesion instead of differential
diagnosis of the malignant lesion. It is necessary to further
investigate if PET or PET/CT can replace biopsy to differ-
entiate between benign lymphoid hyperplasia and malig-
nant lymphoma.
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